Prouroguanylin as therapeutic and diagnostic agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01)

Patent

CA 2567470

A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized by salt retention, fluid retention, salt loss, fluid loss, and combinations thereof. An immunoassay kit for detecting a level of prouroguanylin in a sample.

La présente invention concerne un procédé pour traiter un trouble caractérisé par une rétention de sel, une rétention d'eau et des combinaisons de celles-ci. Elle concerne également un procédé pour déterminer la présence ou la progression d'un trouble caractérisé par une rétention de sel, une rétention d'eau, une perte de sel, une perte d'eau et des combinaisons de celles-ci. En outre, cette invention concerne un kit d'immunoessai pour détecter une concentration de prouroguanyline dans un échantillon.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prouroguanylin as therapeutic and diagnostic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prouroguanylin as therapeutic and diagnostic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prouroguanylin as therapeutic and diagnostic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1371795

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.